PHA310 - Clinical Pharmacokinetics by unknown
  
COMMONWEALTH OF AUSTRALIA 
Copyright Regulations 1969 
Warning 
This material has been reproduced and communicated to you by or on behalf of The 
Charles Darwin University pursuant to Part VB of the Copyright Act 1968 (the Act). 
The material in this communication may be subject to copyright under the Act. Any 
further reproduction or communication of this material by you may be the subject of 
copyright protection under the Act. 
Do not remove this notice 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM 
ANY EXAMINATION VENUE IN ANY CIRCUMSTANCE 
 
Semester 1, 2015 FINAL EXAMINATION 
 PHA310 – Clinical Pharmacokinetics 
Page 1 of 23 
 
 
 Family Name  
Given Names  
Student Number 1 2 3 4 5 6 
Teaching Period Semester 1, 2015 
 
FINAL EXAMINATION DURATION 
PHA310 – Clinical Pharmacokinetics 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
Section A:  
Suggested Time: 60     Multiple Choice Questions: Answer ALL questions : 50 marks  
Section B:  
Suggested Time: 60 Calculations: Answer ALL questions : 100 marks  
Section C:  
Suggested Time: 60 Short Answer Questions & Calculations: Answer ALL questions : 50 marks  
 
Note that questions ARE NOT of equal value. 
EXAM CONDITIONS 
 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
Answer on the supplied examination material/s only 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 
No additional printed material is permitted 
1 x 8 Page Book 
1 x 20 Page Book 
1 x 4-Multiple Choice Answer Sheet 
Formula Sheet/s 
Graph Paper 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM 
ANY EXAMINATION VENUE IN ANY CIRCUMSTANCE 
 
Semester 1, 2015 FINAL EXAMINATION 
 PHA310 – Clinical Pharmacokinetics 
Page 2 of 23 
 
Section A 
Multiple Choice Questions 
Total No of Marks for this section: 50 questions and 50 marks 
This section should be answered on the examination paper provided.   
Please ensure that your name and student number have been written on the examination 
paper.  
ONE mark per each multiple choice question   
Some questions may have more than one correct answer 
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Total Marks for this section: 100 marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section B:  60 mins 
 
Q1. A patient is receiving an antiarrhythmic drug as a constant rate IV infusion of 24 mg/h. 
After 3 days, the drug infusion is terminated and three plasma samples are obtained.  





A. Calculate the CLT and Vd of this drug in this patient.    (5 marks) 
B. The patient again experiences irregular heart rhythm and the doctor wants to start this 
drug again. Recommend an IV loading dose and constant rate infusion that should 
achieve steady state of 10 mg/h.      (5 marks) 
 
 
Q2. A patient is receiving 1000 mg of an antibiotic as repeated IV bolus doses every 12h to treat 
her lung infection. The maximum and minimum steady state plasma concentrations of this 
antibiotic are 48 and 5 mg/L, respectively. 
A. Calculate the Vd and CLT of this antibiotics.      (5 
marks) 
B. Calculate the average plasma concentration of this antibiotic at steady state while 
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Q3. A patient was admitted to hospital after experiencing an episode of ventricular arrhythmia. 
The physician decided to start the patient on IV regimen of an antiarrhythmic drug with Vd of 
45L, the t½ is 7h and the therapeutic range is 4-12 mg/L. 
A. Recommend an IV LD and IV dosing and dose interval that should maintain the drug 
concentration within the therapeutic range all the time.    (5 marks) 
B. The patient was stabilised on the regimen you recommended and she is ready to go 
home. The doctor wants to change to oral administration of the same drug. What will the 
dosing regimen be if the oral product is rapidly absorbed and has bioavailability of 75%?  
 (5 marks) 
 
 
Q4. A 32-year old, 75 kg female has been taking 200mg of phenytoin daily. Because her 
average phenytoin plasma concentration was only 6mg/L, her phenytoin dose is increased to 350 
mg/day. The average steady state plasma concentration of phenytoin is now 21 mg/L (Vd of 
phenytoin is 0.75 L/kg and F=1). 
A. Using the direct linear plot, calculate the phenytoin Vmax and Km in this patient.  
          (5 marks) 
B. Calculate the dose required to achieve an average steady-state phenytoin plasma 
concentration around 15 mg/L.       (5 marks) 
C. Calculate phenytoin half-life at steady sate while the patient was taking 350 mg/day. 
          (5 marks) 
 
Because of poor seizure control, phenobarbitone was added to her medications. After several 
weeks, phenytoin plasma concentration was 14 mg/L while her daily phenytoin dose is 360 
mg.  
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Q5. After a single IV bolus dose of 1000 mg of an antiarrhythmic drug, the following results 
were obtained: 










A. Using the method of residuals, calculate the following parameters: t½α, t½β, k12, k21, 
k10, Vc, Vdss, AUC and CLT.       (10 marks) 
B. What will be the amount of the drug remaining in the body after 15h?  (5 marks)   
 
Q6. After a single IV bolus administration of 50 mg of a drug, the plasma concentrations 
obtained were shown in the following table. λ = 0.1h-1. Calculate the MRT.   
           (20 marks)   
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Q7. In an experiment to investigate the drug absorption from two different oral products of 
the same active drug, a normal volunteer received a single IV bolus dose of 100 mg, a single 
oral dose of 100 mg of formulation A, and single oral dose of 100 mg of formulation B in 
three different occasions. How would you interpret the following data?  (15 marks)   
 
Formulation AUC (μg h/L) AUMC (μg h2/L) 
IV bolus 100 mg 352 1232 
Formulation A 100 mg 264 1056 
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Section C 
Short Answer Questions 
Total No of Marks for this section: 50 marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section B:  60 mins 
 
 
Q1. Define each of the following terms or concepts. 
A. Pharmacokinetics, pharmacokinetics and population pharmacokinetics, 
pharmacodynamics and toxicokinetics. 
B. Linear and non-linear pharmacokinetics 
C. Pharmacokinetic modelling  
D. Pharmacokinetic – pharmacodynamic modelling  
E. Drug distribution process 
F. Drug protein binding, use schematic explanation if possible 
 
(5 marks each = 30 marks) 
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Q2. The calculation of dosing regimens for Drug X may require the following data.   
F = 0.90                                   
Bound in plasma=56%  
Clearance=2.9 L/hr/70kg (constant)  
Volume of distribution=35 L/70kg  
Half-life=8.1 hr  
Effective concentration = 20 mcg/mL  
Toxic concentration=30 mcg/mL 
 
1. A 57-year old adult male (70 kg) who recently suffered a myocardial infarction presents in 
the ER with acute ventricular arrhythmias.  The physician orders a loading dose of Drug X 
to be followed by continuous intravenous dosing to maintain plasma levels of Drug X at an 
effective concentration.  The correct loading dose of this drug to administer would be: 
A. 700 mcg (0.7 mg) 
B. 7000 mcg (7 mg)  
C. 70,000 mcg (70 mg) 
D. 700,000 mcg (700 mg) 
 
2. The intravenous dosing rate necessary to maintain plasma drug levels at 20 mcg/mL is: 
A. 58 mg/hour 
B. 116 mg/hour 
C. 174 mg/hour  
D. 232 mg/hour 
 
3. If a loading dose were not administered, the time required to reach the target plasma level of 
20 mcg/mL would be approximately: 
A. 16-20 hours 
B. 32-40 hours  
C. 80-120 hours 
D. 160-200 hours 
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4. After the patient is discharged, the ORAL MAINTENANCE dose given every 6 hours 
(dosing interval = 6 hours) necessary to maintain plasma drug levels at 20 mcg/mL is: 
A. 309 mg 
B. 348 mg  
C. 387 mg 
D. 426 mg 
 
(5 marks each = 20 marks) 
 
 
 
